"When you say ROI, do you mean return on investment or risk of inaction?" Regarding new technologies, human decision-making is a complicated phenomenon. This is...
Read more"How best in class biopharma companies have reduced their drug waste by 50%" Did you know that the estimated waste level of packaged material in the industry is...
Read more“Clinical Supply Forecasting, Simulations or Optimization? Let me tell you what’s what.“ Over the years, the increasing complexity of trial design has made...
Read moreOn average, between 55-75% of drugs are wasted in clinical trials. Overproduction has historically been accepted in clinical supply and manufacturing processes...
Read moreAlthough vaccine trials are far from the first candidates pharmaceutical companies have in mind when thinking about clinical trial supply optimization, there's...
Read moreEarlier this year, N-SIDE's Alexis Davin and Antoine Remiot teamed up with AstraZeneca's Britta Claesson to present an interesting case study during the annual...
Read moreWe’re at an inflection point for sustainability in clinical trials. As challenges continue to mount, pharma companies must innovate or risk falling behind the...
Read moreOur team is attending Arena Clinical Trial Supply New England! You can meet our Life Sciences team April 5th and 6th at Arena CTS New England in Boston, MA....
Read moreN-SIDE's strategic partnership with Sanofi, aimed at optimizing Sanofi’s clinical trial supply chain has been highlighted by Arnaud Dourlens, Sanofi’s Head of...
Read more